Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GIP Receptor Antagonist GIP-A in Healthy Subjects
NCT02747472Phase 1Completed
- Sponsor
- Gentofte Hospital
- Start
- Apr 2016
- Primary completion
- Jul 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of GIP-A in type 2 diabetes mellitus (T2DM) and obesity (4 arms), sponsored by Gentofte Hospital. Primary endpoint: Insulin levels at 65 minutes. Started Apr 2016; status: completed.
02
Drugs
GIP-A
03
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on NCT02747472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02747472.